MPCCC mission is to advance #cancercare for over 2.1 million Victorians by connecting 8 of Victoria's largest health services with Monash University's #research
Melbourne, Victoria
Joined March 2020
- Tweets614
- Following429
- Followers513
- Likes552
Monash Partners Comprehensive Cancer Consortium retweeted
Thank you to everyone who joined us for @VicCanBioinf Cancer Bioinformatics Australia 25 in Sydney! Huge thank you to my awesome organising committee - I could not have organised this conference without you. Looking forward to seeing you all in Brisbane in 2026!!
Monash Partners Comprehensive Cancer Consortium retweeted
Who is eligible for comprehensive genomic profiling (CGP) through Omico’s Cancer Screening Program (CaSP)? In this short clip from our Cancer & Genomics webinar, A/Prof. Mandy Ballinger explains that free CGP and clinical trial matching is available for Australians with advanced, incurable, or poor prognosis cancers.
▶️ Watch the full webinar on demand to learn more about accessing CGP and how it may help guide your treatment options: lnkd.in/gqRXeJ9n
📘 Download our patient booklet for more details: bit.ly/3XHYdTk
#CancerMeetsItsMatch #ComprehensiveGenomicProfiling #TreatmentMatching #ClinicalTrialMatching #KnowYourOptions #BeYourOwnAdvocate
Monash Partners Comprehensive Cancer Consortium retweeted
Affordable Healthcare Innovation – designed to deliver progress without blowing the budget.💡 Our Precision Oncology Health System Incubator initiative is a smarter, fairer way to invest in healthcare innovation. PrO-HSI isn’t about opening the floodgates to unchecked costs. It’s a carefully structured initiative, with a $30M/year cap and clear performance metrics, ensuring we invest in outcomes that matter and are measurable—without risking affordability or sustainability. PrO-HSI delivers cutting-edge science and better outcomes for rare cancer patients, all while keeping costs in check. Together, we can create a system that’s better for patients and better for Australia. 📄 Learn how we’re balancing innovation with cost control in Omico’s Pre-Budget Submission: lnkd.in/gg9ysC27 #PrOHSI #PrecisionOncology #MainstreamPrecisionOncology #RareCancers #AffordableHealthcare #AccessibleHealthcare #SustainableSolutions #Equity #LeaveNooneBehind @RareCancers @CancerAustralia @cancerNSW
Monash Partners Comprehensive Cancer Consortium retweeted
#CancerNursesDay is a day to recognise the incredible work being done by the 7,500 cancer nurses nationwide and their remarkable contributions to improve patient outcomes in Australia. Visit: cnsa.org.au/congressevents/c… #StrongSkilledSpecialised
Monash Partners Comprehensive Cancer Consortium retweeted
Gippsland prostate cancer patients now have access to a breakthrough treatment that cuts radiation session time down from 20 to 5, as part of partnership between The Alfred and Latrobe Regional Health.
Traralgon man Wayne (left) was the first LRH patient to receive the therapy.
Monash Partners Comprehensive Cancer Consortium retweeted
We’re looking forward to the @RareCancers CanForum 2024, being held on Tuesday 20 August, where we’ll be joining the call for a 'Rare Cancer Moonshot.' We’re part of this a united effort to improve survival for all people diagnosed with cancer. Check out the speaker line up and register online for free virtual attendance at rarecancers.org.au/events/21… and join us in making a Rare Cancer Moonshot a reality! #Canforum24 #RareCancerMoonshot
Monash Partners Comprehensive Cancer Consortium retweeted
"The pace at which this field is advancing means that even recently trained clinicians need continued education to stay up to date.”
– A/Prof Kylie Gorringe, Co-Chair - Foundations Series 2024
@kylie_gorringe
Monash Partners Comprehensive Cancer Consortium retweeted
Be inspired by insights from renowned clinicians and researchers hailing from Australia and New Zealand. Stay up to date with the latest knowledge on how molecular pathways in gynaecological cancer. @YolandAntill
Monash Partners Comprehensive Cancer Consortium retweeted
.@NBCFAus CEO & supporters toured @MonashBDI cancer labs & facilities to witness first-hand the impact of their support on #BreastCancerResearch. We are grateful to NBCF & their supporters for enabling our critical research. More: bit.ly/3XwaZFL
ALT The National Breast Cancer Foundation visit to Monash BDI in June 2024. L-R: A/Prof Lan Nguyen, Prof Roger Daly, Dr Antonella Papa, A/Prof Cleola Anderiesz, Dr Lisa Ooms, Dr Thierry Jarde
Monash Partners Comprehensive Cancer Consortium retweeted
Today is Rare Cancers Awareness Day. Add a fingerprint to our pledge map and help us show support for all those affected by rare and less common cancers: bit.ly/3RF6aX9
Monash Partners Comprehensive Cancer Consortium retweeted
Join us on February 21, 2024, at 12:00 pm for the @MonashPCCC Tech Talk to learn about our novel proteomics solutions SomaScan Assays and how its being used to discover biomarkers that aid in diagnosis, disease severity assessment, and treatment decision-making. Register now!
Monash Partners Comprehensive Cancer Consortium retweeted
Too often, access to #CancerCare is about postcode, not need.
As co-director @MonashPCCC, Prof Mark Shackleton @Shack_Lab is leading efforts to change that, bringing #PrecisionOncology to more people. Here's what he had to say to mark #WorldCancerDay.
mpccc.org.au
ALT Marking #WorldCancerDay on Sunday: The Monash Partners Comprehensive Cancer Consortium (MPCCC), a network of eight of Victoria’s largest hospitals, is working with researchers to rectify the uneven distribution of resources in state-of-the-art #CancerCare across Victoria. Co-Director of MPCCC Professor Mark Shackleton is a Professor of Oncology at the Central Clinical School and the Director of Oncology at Alfred Health, said: “Although all Victorian taxpayers contribute to supporting health care, access to modern cancer care in 2017 was contingent upon one's postcode. This stark reality ignited the MPCCC's mission to tackle inequitable access to #PrecisionOncology, which involves sequencing a patient's cancer tissue to identify genetic changes predicting responses to new treatments and facilitating participation in clinical trials."
Monash Partners Comprehensive Cancer Consortium retweeted
No one knows your skin better than you.
Today is Check for Spots Day, and we’re urging you to check your skin and be all over melanoma.
More: tinyurl.com/muubru8e
Monash Partners Comprehensive Cancer Consortium retweeted
and here it is! A great collaboration with @LanKhuyenNguyen and his lab @MonashBDI to prioritise combination therapies in breast cancer. Thanks to @KelvinHYYip, all co-authors, editors and reviewers!
This is for Giovanna 🩷
nature.com/articles/s41698-0…
Monash Partners Comprehensive Cancer Consortium retweeted
📙 The Melanoma and Skin Cancer Trials 22-23 Annual Report is now available and includes a report on AOMA's achievements for the year.
👉 masc.org.au/annual-reports/
This year's report covers our clinical trials, patient stories, acknowledges our wonderful supporters, and more.
Monash Partners Comprehensive Cancer Consortium retweeted
ON TODAY Don't miss the next @MonashPCCC @MonashBDI Seminar.
𝗦𝗽𝗲𝗮𝗸𝗲𝗿: Asst Prof Derrick Ong @NUSMedicine
𝗧𝗼𝗽𝗶𝗰: Uncovering novel glioblastoma dependencies for mechanism-guided therapies
𝗪𝗵𝗲𝗻: Wed 13 Dec 12-1pm AEDT
Hybrid: Location & Zoom bit.ly/3uCUMgc
Monash Partners Comprehensive Cancer Consortium retweeted
It’s National Skin Cancer Action Week™! ⛱
2 in 3 Australians will be diagnosed with skin cancer in their lifetime.
If the UV is 3 or above, be SunSmart. Save your skin. Slip, Slop, Slap, Seek and Slide. 🙆♂️🧴👒⛱😎
Monash Partners Comprehensive Cancer Consortium retweeted
A/Prof Daniel Gough, Dr Daniel Garama & the team have now identified the processes that #Cancer cells use to create the energy they need to grow.
Read their latest research, on a particular protein called #STAT3, in the journal Cell Reports, or 👉🏾bit.ly/3GbNIPH
ALT Cell image shows the interaction between proteins (green) in the mitochondria (red). The top image is the interaction between STAT3 and SLIRP, bottom is STAT3 and LRPPRC. The blue dye shows the cell nucleus.
Monash Partners Comprehensive Cancer Consortium retweeted
🟣November is #PancreaticCancer awareness month🟣
Fate threw a #publichealth issue our way: #PDAC will be the 2nd leading cause of cancer deaths by 2030. As I contemplate the care J received @ColumbiaSurgery & @MSKCancerCenter I’m reminded that we were lucky……most are not.
Monash Partners Comprehensive Cancer Consortium retweeted
If every cancer is as unique as our fingerprint, what does this mean for the way we design research, treatment and care? Read more at: l8r.it/Zirm
